ANDA 75980, held by Mylan Pharms Inc. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 75980 (Tramadol Hydrochloride), held by Mylan Pharms Inc, was first approved by FDA on Nov 21, 2002, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 21, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tramadol Hydrochloride50MG ยท tablet;oral | Tramadol Hydrochloride | Discontinued |
| Sep 18, 2018 | Supplement 4REMS | Approved | None posted |
| Aug 21, 2006 | Supplement 2Labeling | Approved | None posted |
| Sep 15, 2004 | Supplement 1Labeling | Approved | None posted |
| Nov 21, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters